Report Overview
Report Overview
Advanced therapy medicinal products (ATMPs) are medicines for human use that are based on genes, tissues or cells. They offer groundbreaking new opportunities for the treatment of disease and injury.The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The global Advanced Therapy Medicinal Products market size was estimated at USD 5769.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 10.00% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Advanced Therapy Medicinal Products market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Advanced Therapy Medicinal Products market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Advanced Therapy Medicinal Products market.
Global Advanced Therapy Medicinal Products Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Spark Therapeutics
Bluebird Bio
Novartis
UniQure
Celgene Corporation
Gilead Lifesciences
Kolon TissueGene
JCR Pharmaceuticals
MEDIPOST
Vericel Corporation
PHARMICELL
Market Segmentation (by Type)
Cell Therapy
CAR-T Therapy
Gene Therapy
Tissue Engineered Product
Market Segmentation (by Application)
Hospital
Clinic
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Advanced Therapy Medicinal Products Market
Overview of the regional outlook of the Advanced Therapy Medicinal Products Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Advanced Therapy Medicinal Products Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the markets competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porters five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Advanced Therapy Medicinal Products, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Table of Contents
- 1 Research Methodology and Statistical Scope
- 1.1 Market Definition and Statistical Scope of Advanced Therapy Medicinal Products
- 1.2 Key Market Segments
- 1.2.1 Advanced Therapy Medicinal Products Segment by Type
- 1.2.2 Advanced Therapy Medicinal Products Segment by Application
- 1.3 Methodology & Sources of Information
- 1.3.1 Research Methodology
- 1.3.2 Research Process
- 1.3.3 Market Breakdown and Data Triangulation
- 1.3.4 Base Year
- 1.3.5 Report Assumptions & Caveats
- 2 Advanced Therapy Medicinal Products Market Overview
- 2.1 Global Market Overview
- 2.1.1 Global Advanced Therapy Medicinal Products Market Size (M USD) Estimates and Forecasts (2020-2035)
- 2.1.2 Global Advanced Therapy Medicinal Products Sales Estimates and Forecasts (2020-2035)
- 2.2 Market Segment Executive Summary
- 2.3 Global Market Size by Region
- 2.1 Global Market Overview
- 3 Advanced Therapy Medicinal Products Market Competitive Landscape
- 3.1 Company Assessment Quadrant
- 3.2 Global Advanced Therapy Medicinal Products Product Life Cycle
- 3.3 Global Advanced Therapy Medicinal Products Sales by Manufacturers (2020-2025)
- 3.4 Global Advanced Therapy Medicinal Products Revenue Market Share by Manufacturers (2020-2025)
- 3.5 Advanced Therapy Medicinal Products Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 3.6 Global Advanced Therapy Medicinal Products Average Price by Manufacturers (2020-2025)
- 3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
- 3.8 Advanced Therapy Medicinal Products Market Competitive Situation and Trends
- 3.8.1 Advanced Therapy Medicinal Products Market Concentration Rate
- 3.8.2 Global 5 and 10 Largest Advanced Therapy Medicinal Products Players Market Share by Revenue
- 3.8.3 Mergers & Acquisitions, Expansion
- 4 Advanced Therapy Medicinal Products Industry Chain Analysis
- 4.1 Advanced Therapy Medicinal Products Industry Chain Analysis
- 4.2 Market Overview of Key Raw Materials
- 4.3 Midstream Market Analysis
- 4.4 Downstream Customer Analysis
- 5 The Development and Dynamics of Advanced Therapy Medicinal Products Market
- 5.1 Key Development Trends
- 5.2 Driving Factors
- 5.3 Market Challenges
- 5.4 Industry News
- 5.4.1 New Product Developments
- 5.4.2 Mergers & Acquisitions
- 5.4.3 Expansions
- 5.4.4 Collaboration/Supply Contracts
- 5.5 PEST Analysis
- 5.5.1 Industry Policies Analysis
- 5.5.2 Economic Environment Analysis
- 5.5.3 Social Environment Analysis
- 5.5.4 Technological Environment Analysis
- 5.6 Global Advanced Therapy Medicinal Products Market Porters Five Forces Analysis
- 5.6.1 Global Trade Frictions
- 5.6.2 U.S. Tariff Policy ? April 2025
- 5.6.3 Global Trade Frictions and Their Impacts to Advanced Therapy Medicinal Products Market
- 5.7 ESG Ratings of Leading Companies
- 6 Advanced Therapy Medicinal Products Market Segmentation by Type
- 6.1 Evaluation Matrix of Segment Market Development Potential (Type)
- 6.2 Global Advanced Therapy Medicinal Products Sales Market Share by Type (2020-2025)
- 6.3 Global Advanced Therapy Medicinal Products Market Size by Type (2020-2025)
- 6.4 Global Advanced Therapy Medicinal Products Price by Type (2020-2025)
- 7 Advanced Therapy Medicinal Products Market Segmentation by Application
- 7.1 Evaluation Matrix of Segment Market Development Potential (Application)
- 7.2 Global Advanced Therapy Medicinal Products Market Sales by Application (2020-2025)
- 7.3 Global Advanced Therapy Medicinal Products Market Size (M USD) by Application (2020-2025)
- 7.4 Global Advanced Therapy Medicinal Products Sales Growth Rate by Application (2020-2025)
- 8 Advanced Therapy Medicinal Products Market Sales by Region
- 8.1 Global Advanced Therapy Medicinal Products Sales by Region
- 8.1.1 Global Advanced Therapy Medicinal Products Sales by Region
- 8.1.2 Global Advanced Therapy Medicinal Products Sales Market Share by Region
- 8.2 Global Advanced Therapy Medicinal Products Market Size by Region
- 8.2.1 Global Advanced Therapy Medicinal Products Market Size by Region
- 8.2.2 Global Advanced Therapy Medicinal Products Market Size by Region
- 8.3 North America
- 8.3.1 North America Advanced Therapy Medicinal Products Sales by Country
- 8.3.2 North America Advanced Therapy Medicinal Products Market Size by Country
- 8.3.3 U.S. Market Overview
- 8.3.4 Canada Market Overview
- 8.3.5 Mexico Market Overview
- 8.4 Europe
- 8.4.1 Europe Advanced Therapy Medicinal Products Sales by Country
- 8.4.2 Europe Advanced Therapy Medicinal Products Market Size by Country
- 8.4.3 Germany Market Overview
- 8.4.4 France Market Overview
- 8.4.5 U.K. Market Overview
- 8.4.6 Italy Market Overview
- 8.4.7 Spain Market Overview
- 8.5 Asia Pacific
- 8.5.1 Asia Pacific Advanced Therapy Medicinal Products Sales by Region
- 8.5.2 Asia Pacific Advanced Therapy Medicinal Products Market Size by Region
- 8.5.3 China Market Overview
- 8.5.4 Japan Market Overview
- 8.5.5 South Korea Market Overview
- 8.5.6 India Market Overview
- 8.5.7 Southeast Asia Market Overview
- 8.6 South America
- 8.6.1 South America Advanced Therapy Medicinal Products Sales by Country
- 8.6.2 South America Advanced Therapy Medicinal Products Market Size by Country
- 8.6.3 Brazil Market Overview
- 8.6.4 Argentina Market Overview
- 8.6.5 Columbia Market Overview
- 8.7 Middle East and Africa
- 8.7.1 Middle East and Africa Advanced Therapy Medicinal Products Sales by Region
- 8.7.2 Middle East and Africa Advanced Therapy Medicinal Products Market Size by Region
- 8.7.3 Saudi Arabia Market Overview
- 8.7.4 UAE Market Overview
- 8.7.5 Egypt Market Overview
- 8.7.6 Nigeria Market Overview
- 8.7.7 South Africa Market Overview
- 8.1 Global Advanced Therapy Medicinal Products Sales by Region
- 9 Advanced Therapy Medicinal Products Market Production by Region
- 9.1 Global Production of Advanced Therapy Medicinal Products by Region(2020-2025)
- 9.2 Global Advanced Therapy Medicinal Products Revenue Market Share by Region (2020-2025)
- 9.3 Global Advanced Therapy Medicinal Products Production, Revenue, Price and Gross Margin (2020-2025)
- 9.4 North America Advanced Therapy Medicinal Products Production
- 9.4.1 North America Advanced Therapy Medicinal Products Production Growth Rate (2020-2025)
- 9.4.2 North America Advanced Therapy Medicinal Products Production, Revenue, Price and Gross Margin (2020-2025)
- 9.5 Europe Advanced Therapy Medicinal Products Production
- 9.5.1 Europe Advanced Therapy Medicinal Products Production Growth Rate (2020-2025)
- 9.5.2 Europe Advanced Therapy Medicinal Products Production, Revenue, Price and Gross Margin (2020-2025)
- 9.6 Japan Advanced Therapy Medicinal Products Production (2020-2025)
- 9.6.1 Japan Advanced Therapy Medicinal Products Production Growth Rate (2020-2025)
- 9.6.2 Japan Advanced Therapy Medicinal Products Production, Revenue, Price and Gross Margin (2020-2025)
- 9.7 China Advanced Therapy Medicinal Products Production (2020-2025)
- 9.7.1 China Advanced Therapy Medicinal Products Production Growth Rate (2020-2025)
- 9.7.2 China Advanced Therapy Medicinal Products Production, Revenue, Price and Gross Margin (2020-2025)
- 10 Key Companies Profile
- 10.1 Spark Therapeutics
- 10.1.1 Spark Therapeutics Basic Information
- 10.1.2 Spark Therapeutics Advanced Therapy Medicinal Products Product Overview
- 10.1.3 Spark Therapeutics Advanced Therapy Medicinal Products Product Market Performance
- 10.1.4 Spark Therapeutics Business Overview
- 10.1.5 Spark Therapeutics SWOT Analysis
- 10.1.6 Spark Therapeutics Recent Developments
- 10.2 Bluebird Bio
- 10.2.1 Bluebird Bio Basic Information
- 10.2.2 Bluebird Bio Advanced Therapy Medicinal Products Product Overview
- 10.2.3 Bluebird Bio Advanced Therapy Medicinal Products Product Market Performance
- 10.2.4 Bluebird Bio Business Overview
- 10.2.5 Bluebird Bio SWOT Analysis
- 10.2.6 Bluebird Bio Recent Developments
- 10.3 Novartis
- 10.3.1 Novartis Basic Information
- 10.3.2 Novartis Advanced Therapy Medicinal Products Product Overview
- 10.3.3 Novartis Advanced Therapy Medicinal Products Product Market Performance
- 10.3.4 Novartis Business Overview
- 10.3.5 Novartis SWOT Analysis
- 10.3.6 Novartis Recent Developments
- 10.4 UniQure
- 10.4.1 UniQure Basic Information
- 10.4.2 UniQure Advanced Therapy Medicinal Products Product Overview
- 10.4.3 UniQure Advanced Therapy Medicinal Products Product Market Performance
- 10.4.4 UniQure Business Overview
- 10.4.5 UniQure Recent Developments
- 10.5 Celgene Corporation
- 10.5.1 Celgene Corporation Basic Information
- 10.5.2 Celgene Corporation Advanced Therapy Medicinal Products Product Overview
- 10.5.3 Celgene Corporation Advanced Therapy Medicinal Products Product Market Performance
- 10.5.4 Celgene Corporation Business Overview
- 10.5.5 Celgene Corporation Recent Developments
- 10.6 Gilead Lifesciences
- 10.6.1 Gilead Lifesciences Basic Information
- 10.6.2 Gilead Lifesciences Advanced Therapy Medicinal Products Product Overview
- 10.6.3 Gilead Lifesciences Advanced Therapy Medicinal Products Product Market Performance
- 10.6.4 Gilead Lifesciences Business Overview
- 10.6.5 Gilead Lifesciences Recent Developments
- 10.7 Kolon TissueGene
- 10.7.1 Kolon TissueGene Basic Information
- 10.7.2 Kolon TissueGene Advanced Therapy Medicinal Products Product Overview
- 10.7.3 Kolon TissueGene Advanced Therapy Medicinal Products Product Market Performance
- 10.7.4 Kolon TissueGene Business Overview
- 10.7.5 Kolon TissueGene Recent Developments
- 10.8 JCR Pharmaceuticals
- 10.8.1 JCR Pharmaceuticals Basic Information
- 10.8.2 JCR Pharmaceuticals Advanced Therapy Medicinal Products Product Overview
- 10.8.3 JCR Pharmaceuticals Advanced Therapy Medicinal Products Product Market Performance
- 10.8.4 JCR Pharmaceuticals Business Overview
- 10.8.5 JCR Pharmaceuticals Recent Developments
- 10.9 MEDIPOST
- 10.9.1 MEDIPOST Basic Information
- 10.9.2 MEDIPOST Advanced Therapy Medicinal Products Product Overview
- 10.9.3 MEDIPOST Advanced Therapy Medicinal Products Product Market Performance
- 10.9.4 MEDIPOST Business Overview
- 10.9.5 MEDIPOST Recent Developments
- 10.10 Vericel Corporation
- 10.10.1 Vericel Corporation Basic Information
- 10.10.2 Vericel Corporation Advanced Therapy Medicinal Products Product Overview
- 10.10.3 Vericel Corporation Advanced Therapy Medicinal Products Product Market Performance
- 10.10.4 Vericel Corporation Business Overview
- 10.10.5 Vericel Corporation Recent Developments
- 10.11 PHARMICELL
- 10.11.1 PHARMICELL Basic Information
- 10.11.2 PHARMICELL Advanced Therapy Medicinal Products Product Overview
- 10.11.3 PHARMICELL Advanced Therapy Medicinal Products Product Market Performance
- 10.11.4 PHARMICELL Business Overview
- 10.11.5 PHARMICELL Recent Developments
- 10.1 Spark Therapeutics
- 11 Advanced Therapy Medicinal Products Market Forecast by Region
- 11.1 Global Advanced Therapy Medicinal Products Market Size Forecast
- 11.2 Global Advanced Therapy Medicinal Products Market Forecast by Region
- 11.2.1 North America Market Size Forecast by Country
- 11.2.2 Europe Advanced Therapy Medicinal Products Market Size Forecast by Country
- 11.2.3 Asia Pacific Advanced Therapy Medicinal Products Market Size Forecast by Region
- 11.2.4 South America Advanced Therapy Medicinal Products Market Size Forecast by Country
- 11.2.5 Middle East and Africa Forecasted Sales of Advanced Therapy Medicinal Products by Country
- 12 Forecast Market by Type and by Application (2026-2035)
- 12.1 Global Advanced Therapy Medicinal Products Market Forecast by Type (2026-2035)
- 12.1.1 Global Forecasted Sales of Advanced Therapy Medicinal Products by Type (2026-2035)
- 12.1.2 Global Advanced Therapy Medicinal Products Market Size Forecast by Type (2026-2035)
- 12.1.3 Global Forecasted Price of Advanced Therapy Medicinal Products by Type (2026-2035)
- 12.2 Global Advanced Therapy Medicinal Products Market Forecast by Application (2026-2035)
- 12.2.1 Global Advanced Therapy Medicinal Products Sales (K MT) Forecast by Application
- 12.2.2 Global Advanced Therapy Medicinal Products Market Size (M USD) Forecast by Application (2026-2035)
- 12.1 Global Advanced Therapy Medicinal Products Market Forecast by Type (2026-2035)
- 13 Conclusion and Key Findings